{
    "code": 0,
    "data": [
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript",
            "news_id": "0287dbe0-dac4-470d-bba3-bb42484817b5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6530efc-ce16-4817-b2e8-046cb04387ed.pdf",
            "news_date": "2025-11-14 17:20:39",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "as attached",
            "news_id": "61b4838d-ba5a-4efb-8947-06fab40d1945",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf3953dd-4192-4e75-bb18-ef12c6218972.pdf",
            "news_date": "2025-11-12 13:45:39",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter And Half Year Ended September 30 2025",
            "news_body": "as attached",
            "news_id": "97dcd689-a16a-406b-8b9e-3b7a82e64d40",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d6ae8880-fb55-466f-94b7-135922b84d1c.pdf",
            "news_date": "2025-11-12 13:44:14",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript",
            "news_id": "5f1eab84-b7ba-4db6-b77a-1b52215bfc46",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=35bb43cc-d78b-41bb-ac4d-6a1e8ba46050.pdf",
            "news_date": "2025-08-11 16:53:39",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "a87c531b-325a-4243-81ce-8a1c4ee20734",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=43898fb3-5cce-4a07-a7c3-23a5d48ec076.pdf",
            "news_date": "2025-08-05 13:26:47",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Financial Results For The Quarter Ended June 30 2025",
            "news_body": "Unaudited Financial Results for the quarter ended June 30 2025",
            "news_id": "46e12fe0-cde5-48b9-98ef-2c11b18700bc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=febc630f-73fc-419d-8723-6abecc11fe56.pdf",
            "news_date": "2025-08-05 13:25:26",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings call transcript",
            "news_id": "63759906-fe2d-4f26-8a96-2f46bce64cb0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7de2249-be80-45e8-8a35-6dc4bd2e1430.pdf",
            "news_date": "2025-05-26 11:36:50",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter And Year Ended March 31 2025",
            "news_body": "Financial results",
            "news_id": "34b28e85-c2ba-4eb4-8938-08f06b3e8e58",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f58f50cb-2cc3-43c2-b67e-0aa42d086848.pdf",
            "news_date": "2025-05-19 16:18:59",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation",
            "news_id": "83a59530-0013-4864-9750-173b0747f381",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=48d5ff7a-2fcc-4fb8-8145-41787223363b.pdf",
            "news_date": "2025-05-19 16:11:19",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript",
            "news_id": "812e430e-294e-44e4-a84b-99b4bfce9fe1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=88ddfbb8-52af-4bcb-b79c-b431ef28deb8.pdf",
            "news_date": "2025-02-11 12:38:29",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "d2f9fe7d-388b-4829-bf2a-5d575fd2ff6c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=72908deb-fb0d-4e8f-8d34-bc1eea5aecab.pdf",
            "news_date": "2025-02-04 12:57:26",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Nine Months Ended December 31 2024",
            "news_body": "Financial Results for the Quarter and Nine months ended December 31 2024",
            "news_id": "f782b698-8447-4352-a0a7-fb4c3526fa53",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5ba4d4c3-a91b-40a4-b70c-73a14494fd11.pdf",
            "news_date": "2025-02-04 12:45:55",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Analyst and Investor call.",
            "news_id": "d35e22fc-62e0-4d6f-8eb0-bda399f6b33d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5feadbf2-b6b7-4ee1-a3f6-accf55dc681e.pdf",
            "news_date": "2024-11-04 16:19:50",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "671b626f-517a-4c0c-a02b-f0842f4416ee",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0f54a2a0-d0a2-40e3-94a2-4bc3d50329d7.pdf",
            "news_date": "2024-10-25 13:26:11",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Half Year Ended September 30, 2024",
            "news_body": "Financial Results for the quarter and half year ended September 30, 2024",
            "news_id": "9fda2b26-8774-4e3c-9b55-a151ba0e2c10",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d781a167-448e-4557-bf0e-5f61a1714c69.pdf",
            "news_date": "2024-10-25 13:21:26",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Earnings Call for Quarter ended 30th June 2024",
            "news_id": "cff5ea61-4a22-45bc-a05d-857de8ae9ee7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=22d5725b-2c22-493f-abab-558e99332d8e.pdf",
            "news_date": "2024-08-07 18:37:28",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation for the Quarter Ended 30 June 2024",
            "news_id": "9b7293ee-8686-432d-a852-c2fd8cd60ec4",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4122c193-0660-42e7-a5a6-6515c8fea74a.pdf",
            "news_date": "2024-08-02 14:39:26",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter Ended 30 June 2024",
            "news_body": "Financial Results for the Quarter Ended 30 June 2024",
            "news_id": "8f7ac3df-b437-4507-b8b2-42f77debb1df",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d52a18a0-4ce6-493a-9d9d-fc5de686eb99.pdf",
            "news_date": "2024-08-02 14:31:41",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Earnings Call Transcript",
            "news_id": "136487e1-976c-47bd-b13d-91644e100a94",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6d494d8d-67f5-43fd-bf7d-13b154d6c6f3.pdf",
            "news_date": "2024-05-28 11:44:33",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "17bcdc47-4c1b-4500-aec0-bddc8d991c33",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=38959a43-f6a5-44f8-a6da-60c97a8fb0e1.pdf",
            "news_date": "2024-05-21 18:36:42",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For Quarter And Year Ended 31St March 2024",
            "news_body": "Financial Results for quarter and year ended 31st March 2024",
            "news_id": "b24643b3-8fcc-4662-8d29-1f4ba32629bc",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e7d60efc-6f94-4f51-b438-94775fdc8320.pdf",
            "news_date": "2024-05-21 16:53:03",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Eris Proposes to acquire India Branded Formulations business of Biocon Biologics and 19% stake in Swiss Parenterals Limited",
            "news_id": "dac2a24d-17fb-4874-a1a0-c333892261fd",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1df32023-e9db-42d2-ac0e-0fcd1fb6ae46.pdf",
            "news_date": "2024-03-14 17:41:13",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Analyst and Investor Call",
            "news_id": "ca576b95-03d3-4b12-8763-cc142e715adb",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=afc8f078-09c8-4560-9660-7076629dd9f9.pdf",
            "news_date": "2024-02-20 14:07:28",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor presentation under regulation 30(LODR)",
            "news_id": "41eaaa3d-f4e6-41d3-822d-e023a7d94932",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cf60d05c-0780-4d1a-947b-f4605975c6f5.pdf",
            "news_date": "2024-02-13 18:11:02",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Nine Months Ended December 31, 2023",
            "news_body": "Financial Results for the quarter and nine months ended December 31, 2023",
            "news_id": "f037de79-7889-43a2-816c-1fc79f37b33d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d721e873-1784-4077-aecf-7c997fb83df3.pdf",
            "news_date": "2024-02-13 15:35:48",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Analyst and Investor Call",
            "news_id": "e9a64564-ae2c-4042-9bb0-e8bf3f287552",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ce6cd990-ba5c-4aaa-8a9e-5aa1f634066b.pdf",
            "news_date": "2023-11-11 10:03:21",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "In accordance with the applicable requirements and regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable Regulations, we hereby inform you that the Audio Recording of the Earnings Conference Call in connection with the Unaudited Consolidated and Standalone Financial Results of the Company for the quarter and half year ended September 30, 2023, held on 08 November, 2023, is available on the website of the Company and can be accessed through the following link:Link: https://eris.co.in/financials/",
            "news_id": "672bf7aa-c8e2-43e4-8b95-de927501b6bf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3c44fac3-578a-4751-baf7-230ae9bf4a15.pdf",
            "news_date": "2023-11-08 19:32:51",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "bbb7f84d-6af3-41dc-b84d-8f6cf1313cb7",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c7815d8c-b424-44b5-992a-c3dafd5b0295.pdf",
            "news_date": "2023-11-08 16:07:14",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2023",
            "news_body": "Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2023.",
            "news_id": "7ba39682-ed81-40f3-86c9-5704ee792037",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=52cad9e0-439f-424b-b2e9-46a94939cdaa.pdf",
            "news_date": "2023-11-08 14:22:41",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Transcript of Analyst and Investor Call",
            "news_id": "fe09e0c6-663e-4f2a-82dd-393bdd285461",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=3a6c9020-5515-42db-892c-9676bf917b5c.pdf",
            "news_date": "2023-08-11 14:49:58",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "In accordance with the applicable requirements and regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable Regulations, we hereby inform you that the Audio Recording of the Earnings Conference Call in connection with the Unaudited Consolidated and Standalone Financial Results of the Company for the quarter ended 30th June 2023, held on Monday, 07 August 2023, is available on the website of the Company and can be accessed through the following link:Link: https://eris.co.in/financials/(File name: Q1 FY24-Earnings Call Recording)",
            "news_id": "6c856145-38f1-4484-8041-9744fb1ef9a6",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1888b979-4dfe-470f-8294-dd6969aea380.pdf",
            "news_date": "2023-08-07 18:03:33",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Investor Presentation",
            "news_id": "9a26d275-05ed-41d8-b0fa-44b4405fe678",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb0ce8ff-95a0-44e4-83c8-142403284db7.pdf",
            "news_date": "2023-08-07 13:09:14",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "OUTCOME OF THE BOARD MEETING HELD TODAY, I.E., AUGUST 07, 2023",
            "news_body": "Outcome of the Board Meeting held today, i.e., August 07, 2023",
            "news_id": "7001fb83-c595-485b-a8da-9625bff99a4d",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e5744c5e-64b0-492d-a77b-4f3bfd8096c7.pdf",
            "news_date": "2023-08-07 13:04:41",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for OUTCOME OF THE BOARD MEETING HELD TODAY, I.E., AUGUST 07, 2023",
            "news_body": "Dear Sir/Madam,<BR> <BR> Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e., August 07, 2023, inter alia, duly approved/took on record the following:<BR> <BR> ? The limited reviewed unaudited Standalone & Consolidated Financial Results for the quarter ended June 30, 2023;<BR> <BR> ? Convening of 17th Annual General Meeting of the Members of the Company on Monday, September 25, 2023.<BR> <BR> Please find enclosed limited reviewed standalone and consolidated unaudited financial results for the quarter ended June 30, 2023<BR> <BR> The meeting of the Board of Directors commenced at 11:00 A.M. and concluded at 12:50 P.M.<BR> <BR> This is for your information and record.",
            "news_id": "66fd6d5f-293a-4e5c-9c5f-48a7b68ac220",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=44d168e3-2c15-4b28-9c0f-78de3dc0614f.pdf",
            "news_date": "2023-08-07 13:00:31",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "This is to inform that the transcript of the Analyst and Investor call which was held after the announcement of financial results for the quarter and year ended 31st March 2023 is available on our website URL https://eris.co.in/financials/ (File name: Transcript of the Analyst and Investor Conference Call Q4FY23).",
            "news_id": "eb5f3910-87e4-4117-8c7c-fdead8f0ca22",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fbac3ee9-107e-4c1f-92d4-ef90c8079efe.pdf",
            "news_date": "2023-05-22 17:33:23",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Dear Sir/Madam,In accordance with the applicable requirements and regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable Regulations, we wish to inform you that the Audio Recording of the Earnings Conference Call in connection with the Consolidated and Standalone Audited Financial Results of the Company for the Quarter and Financial Year ended March 31, 2023, held on May 17, 2023, is available on the website of the Company and can be accessed through the following link:Link: https://eris.co.in/financials/(File name: Q4 FY23 Earnings Call Recording)",
            "news_id": "16ffb14a-1659-44a9-a22e-2349a7bef3f3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6f954922-c5f0-4fe9-90ac-99c3cf488144.pdf",
            "news_date": "2023-05-17 20:39:51",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Dear Sir/Madam,Pursuant to the requirement of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached investor presentation made by the Company.Thanking you.",
            "news_id": "a89b757d-15e1-4312-8bc3-4f60888a5dc3",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=46495ad9-88fb-492a-8bd6-fa57aa2402e9.pdf",
            "news_date": "2023-05-17 14:49:31",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "OUTCOME OF THE BOARD MEETING",
            "news_body": "In accordance with the provisions of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company at their meeting held on 17th May, 2023 has, inter alia, transacted the following business:<BR> <BR> The Board of Directors duly approved and took on record the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2023.<BR> <BR> We hereby declare that M/s. Deloitte Haskins & Sells LLP, Chartered Accountants, Statutory Auditors of the Company has issued its Audit Report with unmodified opinion on the Standalone and Consolidated Financial Results of the Company for the year ended 31st March, 2023.<BR> <BR> The duly signed Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2023 along with the Auditor''s Report are enclosed.<BR> <BR> The meeting of Board of Directors commenced on 11:00 A.M. and concluded on 02:20 P.M.",
            "news_id": "88991b4d-4b35-4458-ba61-e4b968146243",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=607ec38d-fd39-4e06-95d7-30ffa050f191.pdf",
            "news_date": "2023-05-17 14:43:07",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for OUTCOME OF THE BOARD MEETING",
            "news_body": "In accordance with the provisions of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company at their meeting held on 17th May, 2023 has, inter alia, transacted the following business:<BR> <BR> The Board of Directors duly approved and took on record the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2023.<BR> <BR> We hereby declare that M/s. Deloitte Haskins & Sells LLP, Chartered Accountants, Statutory Auditors of the Company has issued its Audit Report with unmodified opinion on the Standalone and Consolidated Financial Results of the Company for the year ended 31st March, 2023.<BR> <BR> The duly signed Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2023 along with the Auditor''s Report are enclosed.<BR> <BR> The meeting of Board of Directors commenced on 11:00 A.M. and concluded on 02:20 P.M.",
            "news_id": "ba53336d-11e0-4278-86e8-8160eed68fee",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e2dd5d0b-6b57-4b92-9a91-a8400c3c40fd.pdf",
            "news_date": "2023-05-17 14:36:10",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Analyst / Investor Meet",
            "cat": "Audio",
            "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
            "news_body": "Dear Sir/Madam,This is to inform that the Audio Recording of the Conference Call which was held on Thursday, 16 March 2023 in connection with the acquisition of nine dermatology brands from Dr. Reddy''s Laboratories Ltd., is available on the website of the Company and can be accessed through the following link: Link: https://eris.co.in/announcements-notices/  (File name: Conference call recording)",
            "news_id": "a869b509-9fb9-44cb-9751-ea1b2a031e6b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=7de0d7d3-646e-46fe-ad01-8dc688bade25.pdf",
            "news_date": "2023-03-16 19:32:04",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Dear Sir/Madam,This is to inform that the transcript of the Analyst and Investor call which was held after the announcement of financial results for the quarter ended, 31st December 2022 is available on our website URL https://eris.co.in/financials/(File name: Transcript of the Analyst and Investor Conference Call Q3FY23).",
            "news_id": "cd4646f4-d9cd-497d-b518-431933e3b370",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b0256c04-5959-402a-8bb7-179fa838540e.pdf",
            "news_date": "2023-01-23 19:17:15",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "AUDIO RECORDING OF THE EARNINGS CONFERENCE CALL ON THE UNAUDITED CONSOLIDATED AND STANDALONE FINANCIAL RESULTS OF THE COMPANY FOR THE QUARTER AND NINE MONTHS ENDED 31ST DECEMBER 2022",
            "news_body": "Dear Sir/Madam,In accordance with the applicable requirements and regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable Regulations, we hereby inform you that the Audio Recording of the Earnings Conference Call in connection with the Unaudited Consolidated and Standalone Financial Results of the Company for the quarter and nine months ended 31st December 2022, held on Tuesday, 17 January 2023, is available on the website of the Company and can be accessed through the following link:Link: https://eris.co.in/financials/(File name: Q3 FY23-Earnings Call Recording)Thanking You,",
            "news_id": "98e2b0fa-40cc-403a-a94b-53be68752445",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0ac7e9c7-35a5-453f-8f88-eb76d98c04c4.pdf",
            "news_date": "2023-01-17 20:55:30",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "INVESTOR PRESENTATION",
            "news_id": "1a852b0d-27f1-4630-bec2-b3c60c76e4a5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=eaaac04b-0902-4030-8b88-2477f2762fc5.pdf",
            "news_date": "2023-01-17 17:38:02",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "OUTCOME OF THE BOARD MEETING HELD TODAY, I.E., JANUARY 17, 2023",
            "news_body": "Dear Sir/Madam,<BR> <BR> The Board of Directors of the Company at their meeting held today, i.e., January 17, 2023 duly approved and took on record the limited reviewed Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2022.<BR> <BR> Please find enclosed standalone and consolidated unaudited financial results for the quarter and nine months ended December 31, 2022.<BR>  <BR> The meeting of the Board of Directors commenced at 11:30 A.M. and concluded at 05:20 P.M.<BR> <BR> This is for your information and record.<BR> <BR> Thanking You,<BR>",
            "news_id": "46d07801-7560-41da-828c-7988c0f9cb19",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8b809203-a193-41ba-8f48-b46272f81055.pdf",
            "news_date": "2023-01-17 17:36:21",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for OUTCOME OF THE BOARD MEETING HELD TODAY, I.E., JANUARY 17, 2023",
            "news_body": "Dear Sir/Madam,<BR> <BR> The Board of Directors of the Company at their meeting held today, i.e., January 17, 2023 duly approved and took on record the limited reviewed Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2022.<BR> <BR> Please find enclosed standalone and consolidated unaudited financial results for the quarter and nine months ended December 31, 2022.<BR>  <BR> The meeting of the Board of Directors commenced at 11:30 A.M. and concluded at 05:20 P.M.<BR> <BR> This is for your information and record.<BR> <BR> Thanking You,",
            "news_id": "a3bc73fd-9f78-497b-8c94-7491b46e5988",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=58b37e96-e5bd-431b-8399-16348a221af1.pdf",
            "news_date": "2023-01-17 17:33:30",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "DISCLOSURES OF RELATED PARTY TRANSACTIONS UNDER REGULATION 23(9) OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015, AS AMENDED ('SEBI LISTING REGULATIONS')",
            "news_body": "DISCLOSURES OF RELATED PARTY TRANSACTIONS UNDER REGULATION 23(9) OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015, AS AMENDED ('SEBI LISTING REGULATIONS')",
            "news_id": "2064af04-0b67-4a52-898a-8294328557ff",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e0b883fe-cfc4-49a5-815a-731da1325c87.pdf",
            "news_date": "2022-11-04 19:38:26",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "TRANSCRIPT OF ANALYST AND INVESTOR CALL",
            "news_id": "461d5486-4ace-44a9-991b-45cd708de8ce",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b06d495f-157c-413f-9aca-cc970cf2bd4f.pdf",
            "news_date": "2022-10-31 18:48:39",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "AUDIO RECORDING OF THE EARNINGS CONFERENCE CALL ON THE UNAUDITED CONSOLIDATED AND STANDALONE FINANCIAL RESULTS OF THE COMPANY FOR THE QUARTER AND HALF YEAR ENDED 30TH SEPTEMBER 2022",
            "news_body": "Dear Sir/Madam,In accordance with the applicable requirements and regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable Regulations, we hereby inform you that the Audio Recording of the Earnings Conference Call in connection with the Unaudited Consolidated and Standalone Financial Results of the Company for the quarter and half year ended 30th September 2022, held on 20th October 2022, is available on the website of the Company and can be accessed through the following link:Link: https://eris.co.in/financials/(File name: Q2 FY23-Earnings Call Recording)",
            "news_id": "472556aa-d1e5-4d36-b597-056e6926fa03",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=99743703-c397-481c-a85d-4f9285348606.pdf",
            "news_date": "2022-10-20 18:32:43",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to the requirement of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the investor presentation made by the Company.",
            "news_id": "2dd5aa35-79be-4662-8920-68c6be2744c9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=79f1006e-99f9-4766-be63-a36922f8387a.pdf",
            "news_date": "2022-10-20 13:01:32",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for OUTCOME OF THE BOARD MEETING",
            "news_body": "We hereby inform that the Board of Directors of the Company at their meeting held today i.e. 20 October 2022 has, inter alia, transacted the following business:<BR> ? Approved and took on record the limited reviewed Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30th September 2022.<BR> <BR> The duly signed Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30th September 2022 are enclosed herewith.<BR> <BR> ? The Board considered the re-classification request received from M/s. Shah & Co. The Board reviewed the application received and formed a view that the said request does not prejudice the interests of the Company and its stakeholders in any manner. The Board, therefore, approved the proposal and approved its reference to the stock exchanges for their approval in terms of Regulation 31A of Listing Regulations.<BR> <BR> The meeting of the Board of Directors commenced at 11:00 A.M. and concluded at 12:30 P.M.<BR>",
            "news_id": "05499494-dc49-4d31-beb3-798ab3a0bf70",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=c5a989e3-8575-468a-8f79-d245976e9a93.pdf",
            "news_date": "2022-10-20 12:49:27",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For The Quarter And Half Year Ended 30Th September, 2022",
            "news_body": "We hereby inform that the Board of Directors of the Company at their meeting held today i.e. 20 October 2022 has, inter alia, transacted the following business:<BR> <BR> ? Approved and took on record the limited reviewed Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30th September 2022.<BR> The duly signed Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended 30th September 2022 are enclosed herewith.<BR> <BR> ? The Board considered the re-classification request received from M/s. Shah & Co. The Board reviewed the application received and formed a view that the said request does not prejudice the interests of the Company and its stakeholders in any manner. The Board, therefore, approved the proposal and approved its reference to the stock exchanges for their approval in terms of Regulation 31A of Listing Regulations.<BR>",
            "news_id": "a90ba72f-7abe-4618-bd4b-fcb1f37cbd5a",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=53641840-b0b3-4744-ae59-130d9f4b8f98.pdf",
            "news_date": "2022-10-20 12:43:04",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Dear Sir/Madam,Kindly note that the transcript of the Analyst and Investor call which was held after the announcement of financial results for the quarter ended 30 June 2022 is available on our website URL https://eris.co.in/financials/(File name: Transcript of the Analyst and Investor Conference Call Q1FY23).Thanking You,",
            "news_id": "ba46876d-8877-4de6-9382-c08743d555ee",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b284a49c-e863-4b69-a84d-65ca4be1b71e.pdf",
            "news_date": "2022-08-11 12:05:37",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "AUDIO RECORDING OF THE EARNINGS CONFERENCE CALL ON THE CONSOLIDATED AND STANDALONE UNAUDITED FINANCIAL RESULTS OF THE COMPANY FOR THE QUARTER YEAR ENDED 30 JUNE 2022",
            "news_body": "In accordance with the applicable requirements and regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable Regulations, we hereby inform you that the Audio Recording of the Earnings Conference Call in connection with the Consolidated and Standalone Unaudited Financial Results of the Company for the quarter ended 30 June 2022, held on 05 August 2022",
            "news_id": "58bea98c-6cff-4e7c-9701-adb9c5495ca5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=be3951ba-affb-4661-b7eb-d7d15c73a9c7.pdf",
            "news_date": "2022-08-05 17:55:33",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "OUTCOME OF THE BOARD MEETING",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e., 05 August 2022, inter alia, duly approved/took on record the following:? Unaudited Standalone Financial Results and Unaudited Consolidated Financial Results for the quarter ended 30 June 2022;? Declaration of interim dividend of Rs. 7.35/- (at the rate of 735%) on each fully paid-up equity share of Re. 1/- for the Financial Year 2022-2023;? Further, as Communicated in our intimation letter dated 02 August 2022, the record date for determining the eligibility of shareholders for the payment of the interim dividend has been fixed as 16 August 2022. The payment of interim dividend would be made to the eligible shareholders on or before 04 September 2022.The Board Meeting commenced at 11:00 A.M. and concluded at 12:35 P.M.Kindly take the above information on your records.",
            "news_id": "5e0e60d9-9a25-4885-9554-4b0e9a10b9cf",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b273a828-6572-41ca-a87f-a7ab72d9ca5e.pdf",
            "news_date": "2022-08-05 13:25:48",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to the requirement of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached the investor presentation made by the Company.",
            "news_id": "3c3960bc-61dc-4687-b621-37d5d58ae26f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0a015877-9d65-4cac-9fac-c90fdcba7da8.pdf",
            "news_date": "2022-08-05 13:01:17",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for OUTCOME OF THE BOARD MEETING",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e., 05 August 2022, inter alia, duly approved/took on record the following:<BR> <BR> ? Unaudited Standalone Financial Results and Unaudited Consolidated Financial Results for the quarter ended 30 June 2022;<BR> <BR> ? Declaration of interim dividend of Rs. 7.35/- (at the rate of 735%) on each fully paid-up equity share of Re. 1/- for the Financial Year 2022-2023;<BR> <BR> ? Further, as Communicated in our intimation letter dated 02 August 2022, the record date for determining the eligibility of shareholders for the payment of the interim dividend has been fixed as 16 August 2022. The payment of interim dividend would be made to the eligible shareholders on or before 04 September 2022.<BR>",
            "news_id": "3f63a2cc-99a1-4f39-b1d9-6ce6422cf6b2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e0e8af84-dd52-4b67-89c9-397a84c33242.pdf",
            "news_date": "2022-08-05 12:55:58",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "DISCLOSURES OF RELATED PARTY TRANSACTIONS UNDER REGULATION 23(9) OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015, AS AMENDED ('SEBI LISTING REGULATIONS')",
            "news_body": "Pursuant to Regulation 23(9) of the SEBI Listing Regulations, please find enclosed herewith disclosures of related party transactions on consolidated basis in the revised format, as prescribed by SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated 22 November 2021, for the half-year ended commencing from 1 October 2021 to 31 March 2022.Kindly take note the same.",
            "news_id": "8e44cecd-73f8-41cd-a952-6b3eeebb41e9",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f8bf0728-f4e1-4c3d-b278-35245b4cf1f6.pdf",
            "news_date": "2022-05-30 13:53:59",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "TRANSCRIPT OF ANALYST AND INVESTOR CALL",
            "news_id": "d9817e00-f496-408b-9b6a-08a5d3e14a93",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6791b736-2f9d-449b-bd8a-b4b76aa83744.pdf",
            "news_date": "2022-05-10 10:50:15",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "General",
            "cat": "Audio",
            "caption": "AUDIO RECORDING OF THE EARNINGS CONFERENCE CALL",
            "news_body": "Dear Sir/Madam,In accordance with the applicable requirements and regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable Regulations, we wish to inform you that the Audio Recording of the Earnings Conference Call in connection with the Consolidated and Standalone Audited Financial Results of the Company for the Financial Year ended March 31, 2022, held on May 4, 2022, is available on the website of the Company and can be accessed through the following link:Link: https://eris.co.in/financials/(File name: Q4 FY22 Earnings Call Recording)",
            "news_id": "5168421f-b57f-4c82-929e-74b1ce82f420",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9065fdab-b265-4f7f-87a3-cf075413c5d3.pdf",
            "news_date": "2022-05-05 11:07:25",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to the requirement of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached investor presentation made by the Company.",
            "news_id": "650aaed8-cfd1-4d88-936e-43d975f9147c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=6579cb00-4865-45c5-bd01-558683663330.pdf",
            "news_date": "2022-05-03 14:02:37",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "OUTCOME OF THE BOARD MEETING",
            "news_body": "The Board of Directors of the Company at their meeting held today i.e. May 03, 2022 duly approved and took on record the Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2022.<BR> We hereby declare that M/s. Deloitte Haskins & Sells LLP, Chartered Accountants, Statutory Auditors of the Company has issued its Audit Report with unmodified opinion on the Standalone and Consolidated Financial Results of the Company for the year ended 31st March, 2022.<BR> Please find enclosed herewith the duly signed Audited Standalone and Consolidated Financial Results for the quarter and year ended March 31, 2022 along with the Auditor''s Report.",
            "news_id": "7f14e4cf-2d08-4ad4-8e3d-43526e0bf83c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9542f7ac-2611-46b9-a218-a2bbd40412fd.pdf",
            "news_date": "2022-05-03 13:52:20",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "Dear Sir/Madam,This is to inform that the transcript of the Analyst and Investor call which was held after the announcement of financial results for the quarter and nine month ended 31st December, 2021 is available on our website URL https://eris.co.in/financials/(File name: Transcript of the Analyst and Investor Conference Call-Q3FY22).",
            "news_id": "33dccfcf-503c-4e09-9876-0c06b4079051",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f3d7e64e-8635-4172-8cf1-80f15ea73917.pdf",
            "news_date": "2022-02-03 14:39:41",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "CORPORATE PRESENTATION DATED 2ND FEBRUARY,2022.",
            "news_id": "08862923-ae03-4894-a4ef-aba764407678",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=54cda3c5-e5c6-41fe-93ca-ef1db3524fc0.pdf",
            "news_date": "2022-02-02 16:50:19",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to the requirement of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached investor presentation made by the Company.",
            "news_id": "236f23da-9a23-44b7-be32-fffc40232c9c",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=163e4726-8c3e-46ea-a2c9-b165f3c51559.pdf",
            "news_date": "2022-01-28 12:52:21",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Financial Results For The Quarter And Nine Months Ended 31St December, 2021",
            "news_body": "The Board of Directors of the Company at their meeting held today i.e. January 28, 2022 duly approved and took on record the limited reviewed Unaudited Standalone Financial Results and the limited reviewed Unaudited Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2021.",
            "news_id": "6e66d34f-ebd3-4393-81b9-c041919f153e",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f071dd97-e0bd-4e33-8fc7-447d1e9530b6.pdf",
            "news_date": "2022-01-28 12:49:13",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for OUTCOME OF THE BOARD MEETING",
            "news_body": "The Board of Directors of the Company at their meeting held today i.e. January 28, 2022 duly approved and took on record the limited reviewed Unaudited Standalone Financial Results and the limited reviewed Unaudited Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2021.",
            "news_id": "4f17c6bc-7bb0-4ff7-b574-88ae4f848bff",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=253bcce6-f0df-4a7c-93a7-418eb3bda6b0.pdf",
            "news_date": "2022-01-28 12:44:39",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "TRANSCRIPT OF ANALYST AND INVESTOR CALL",
            "news_id": "da841743-4b68-4aee-a76d-40752b2ba72f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a151f8af-5a3d-4ae8-b732-8fd23b702f17.pdf",
            "news_date": "2021-11-01 17:59:42",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "INVESTOR PRESENTATION",
            "news_id": "71d4eb75-0a2e-4749-9f65-ef55d59215f2",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2431def8-80bb-408f-aaa3-002f4d21c3f4.pdf",
            "news_date": "2021-10-29 13:20:13",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Results-Financial Results For September 30, 2021",
            "news_body": "The Board of Directors of the Company at their meeting held today i.e. October 29, 2021 duly approved and took on record the limited reviewed Unaudited Standalone Financial Results and the limited reviewed Unaudited Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2021.",
            "news_id": "5d49d233-0967-473e-a1b2-ac6d50870a7f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=95f49efd-7499-4f9c-ade0-b71c88618c77.pdf",
            "news_date": "2021-10-29 13:11:28",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for OUTCOME OF THE BOARD MEETING HELD TODAY, I.E. OCTOBER 29, 2021",
            "news_body": "The Board of Directors of the Company at their meeting held today i.e. October 29, 2021 duly approved and took on record the limited reviewed Unaudited Standalone Financial Results and the limited reviewed Unaudited Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2021.",
            "news_id": "db4046e4-a40c-49c4-84d8-48ea18d7405b",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a1de5616-6be7-4000-8e81-2a2a0d6b7394.pdf",
            "news_date": "2021-10-29 13:02:42",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to the requirement of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached corporate presentation made by the Company.",
            "news_id": "dceb2a82-7ec1-4afb-a219-13dc45d0ea02",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ae981df5-8184-4814-844b-01aed97b9d79.pdf",
            "news_date": "2021-08-03 15:14:11",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "OUTCOME OF THE BOARD MEETING HELD TODAY, I.E. JULY 29, 2021",
            "news_body": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that the Board of Directors of the Company, in their meeting held today, i.e., July 29, 2021 inter alia, duly approved / took on record the following:<BR> ? Unaudited Standalone Financial Results and Unaudited Consolidated Financial Results for the quarter ended June 30, 2021;<BR> ? Convening of Annual General Meeting (AGM) of the Members of the Company on Wednesday, September 01, 2021.<BR> ? Declaration of interim dividend of Rs. 6.01 (at the rate of 601%) on each fully paid-up equity share of Re. 1/- for the Financial Year 2021-2022;<BR> ? Further, as Communicated in our intimation letter dated July 26, 2021, the record date for determining the eligibility of shareholders for payment of interim dividend has been fixed as August 6, 2021. The payment of interim dividend would be made to the eligible shareholders on or before August 28, 2021.<BR> <BR>",
            "news_id": "a32da8f4-7429-4af3-9a13-5106775ea157",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e6d38f72-bf1d-4b90-a75b-8d4f1c5928f9.pdf",
            "news_date": "2021-07-29 13:57:08",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to the requirement of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached investor presentation to be made by the Company.<BR> <BR> <BR>",
            "news_id": "88150286-09e3-4a19-a269-dc8959acd73f",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=271b7650-1a3b-4bad-b8d4-88ede5bc49ac.pdf",
            "news_date": "2021-07-29 13:16:30",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Board Meeting Outcome for SUBJECT: OUTCOME OF THE BOARD MEETING HELD TODAY, I.E. JULY 29, 2021",
            "news_body": "? Unaudited Standalone Financial Results and Unaudited Consolidated Financial Results for the quarter ended June 30, 2021;<BR> <BR> ? Convening of Annual General Meeting (AGM) of the Members of the Company on Wednesday, September 01, 2021.<BR> <BR> ? Declaration of interim dividend of Rs. 6.01 (at the rate of 601%) on each fully paid-up equity share of Re. 1/- for the Financial Year 2021-2022;<BR> <BR> ? Further, as Communicated in our intimation letter dated July 26, 2021, the record date for determining the eligibility of shareholders for payment of interim dividend has been fixed as August 6, 2021. The payment of interim dividend would be made to the eligible shareholders on or before August 28, 2021.",
            "news_id": "246e883b-adb5-45ee-a951-632c180d6632",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=5ca012da-f4e8-4c59-9294-10baee54111f.pdf",
            "news_date": "2021-07-29 13:12:22",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Earnings Call Transcript",
            "cat": "Transcript",
            "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
            "news_body": "INTIMATION OF SCHEDULE OF ANALYST & INVESTOR CALL PURSUANT TO REGULATION 30 AND OTHER APPLICABLE REGULATIONS OF THE SECURITIES AND EXCHANGE BOARD OF INDIA (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 (SEBI LODR, 2015)",
            "news_id": "459bffac-e4e8-40e2-88de-282b20a5bf58",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bf03a5af-e1c0-4807-a569-df745ab80bd3.pdf",
            "news_date": "2021-07-22 18:19:48",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Compliance Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure<BR> Requirements) Regulations, 2015",
            "news_body": "As per the requirements of Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements)<BR> Regulations, 2015, please find enclosed the details of the related party transactions on a consolidated basis<BR> for the year ended 31st March, 2021 in accordance with the format prescribed in the relevant accounting<BR> standards.",
            "news_id": "df63b180-24cc-4cbd-9cb2-d6d8ee368ec0",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=30156d73-473a-4127-bd7f-f448b9924266.pdf",
            "news_date": "2021-06-11 20:51:45",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "Result For March, 2021",
            "news_body": "The Board of Directors of the Company at their meeting held today i.e. May 13, 2021 duly approved and took on record the Audited Standalone Financial Results and the Audited Consolidated Financial Results for the quarter and year ended March 31, 2021.<BR> <BR> We hereby declare that M/s. Deloitte Haskins & Sells LLP, Chartered Accountants, Statutory Auditors of the Company has issued its Audit Report with unmodified opinion on the standalone and the consolidated Financial Results of the Company for the year ended 31st March, 2021.<BR> <BR> Please find enclosed herewith the duly signed Audited Standalone Financial Results and the Audited Consolidated Financial Results for the quarter and year ended March 31, 2021 along with the Auditor''s Report.<BR>",
            "news_id": "9821a825-0f63-4768-a6a7-7ff0136471b5",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=85639f6f-67f4-4093-b596-005f44717683.pdf",
            "news_date": "2021-05-13 17:44:47",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Investor Presentation",
            "cat": "Investor Presentation",
            "caption": "Announcement under Regulation 30 (LODR)-Investor Presentation",
            "news_body": "Pursuant to the requirement of Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached investor presentation to be made by the Company.",
            "news_id": "ce970817-be98-445b-8c7f-e0ecf8a9f808",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e4ec3bde-d087-42bb-a12c-812935515dcb.pdf",
            "news_date": "2021-05-13 15:04:18",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        },
        {
            "sym": "ERIS",
            "disp": "Eris Lifesciences",
            "bse_code": 540596,
            "isin": "INE406M01024",
            "descriptor": "Financial Results",
            "cat": "Financial Results",
            "caption": "OUTCOME OF THE BOARD MEETING",
            "news_body": "The Board of Directors of the Company at their meeting held today i.e. May 13, 2021 duly approved and took on record the Audited Standalone Financial Results and the Audited Consolidated Financial Results for the quarter and year ended March 31, 2021.   <BR> <BR> We hereby declare that M/s. Deloitte Haskins & Sells LLP, Chartered Accountants, Statutory Auditors of the Company has issued its Audit Report with unmodified opinion on the standalone and the consolidated Financial Results of the Company for the year ended 31st March, 2021.<BR> <BR> Please find enclosed herewith the duly signed Audited Standalone Financial Results and the Audited Consolidated Financial Results for the quarter and year ended March 31, 2021 along with the Auditor''s Report.<BR>",
            "news_id": "4b2c6952-c36a-4584-aeb1-035bcfea17f1",
            "file_url": "https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8eadb0f9-c110-4f6a-950e-f7b06dd75dab.pdf",
            "news_date": "2021-05-13 14:55:40",
            "seo": "eris-lifesciences-ltd",
            "ltp": 1469.2,
            "ch": 3.7999999999999545,
            "pch": 0.2593148628360826,
            "inst": "EQUITY",
            "ts": 0.1,
            "ls": 1,
            "mtp": 1,
            "sid": 21154,
            "exch": "NSE",
            "seg": "E"
        }
    ],
    "remarks": ""
}